Your gateway to a free society
Article

Coinbase Exec Says Clarity Act Has 'Tremendous Momentum' In The Senate

Coinbase Exec Says Clarity Act Has 'Tremendous Momentum' In The Senate Authored by Micah Zimmerman via BitcoinMagazine.com, Coinbase Vice Chair Ryan VanGrack said the Clarity Act has gained “tremendous momentum” in the Senate, in a CNBC “Squawk Box” appearance that made the case for a federal crypto framework and touched on bitcoin, blockchain, and the industry’s uneasy truce with Wall Street. VanGrack, a former SEC official, framed the Clarity Act as an overdue set of rules rather than a giveaway. “It’s not about no regulation,” he said. “This is about imposing regulation on the industry for the first...
Back

aboutLiberty Portal

Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Jul 7, 2026 / Tyler Durden
Ukrainian Drone Swarm Attack Hits Eight Russian 'Shadow Fleet' Tankers
Sep 4, 2026 / Tyler Durden
'Good News Is Bad News': Big Jobs Beats Sends Rate-HIKE Odds Soaring; Batters Bonds, Stocks, Gold
'Good News Is Bad News': Big Jobs Beats Sends Rate-HIKE Odds Soaring; Batters Bonds, Stocks, Gold A four standard deviation beat for non-farm payrolls this morning (good news) is triggering ugly reactions (bad news) across markets with rate-hike odds for September ripping back up near recent highs (despite no signs of inflationary wage growth - in fact it is slowing)... Audrey Childe-Freeman, Bloomberg Intelligence’s chief FX strategist: “The strength in the latest NFP report will validate Sept. Fed rate-rise talks and most likely give the dollar a short-term-yield-driven lift.” “But that’s priced, and...
Read more
Aug 27, 2026 / Tyler Durden
FDA Clears Blood Test To Detect Signs Of Alzheimer's Disease
FDA Clears Blood Test To Detect Signs Of Alzheimer's Disease Federal regulators have cleared a blood test aimed at detecting signs of Alzheimer's disease. The Food and Drug Administration cleared a blood test known as Elecsys pTau-217 for people aged at least 55 who have shown signs of, or have been complaining of, cognitive decline, Roche announced on Aug. 24. The test, which can be used by primary care doctors and specialists, detects a biomarker called plasma phosphorylated tau 217. In a study that ran from 2004 to 2025 and was published...
Read more

support

If you like what we do and want to support us, then you are a fine humanitarian. Click the link below to find out more.

Support the liberty movement